To the content
3 . 2013

The effect of derivative bicyclic bisurea on lipid metabolism in patients with angina FC I-III

Keywords:angina, anxiety disorder, depression, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides

Objective: to determine the influence of adaptol, the company OlainFarm, Latvia) on lipid metabolism in patients with coronary artery disease angina FC I-III. Research methods: clinical and historical data, ECG in 12-lead ECG, daily Holter ECG monitoring, Bicycle ergometry, determination of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, questionnaires for evaluation of anxiety/depression HADS, Ces-D, Buck.

Results: the study included 104 patients with coronary artery disease angina FC I-III in aged from 34 to 71 years, who were divided into 3 groups. In the I group consisted of 42 patients with coronary artery disease, angina FC I-III with anxiety disorders, in some cases in conjunction with depression, which was administered adaptol 500 mg 2 times a day for two months; in the II – 43 patients with CHD, angina FC I-III without anxiety disorders, who was therapy adaptol 500 mg 2 times a day for two months; III - the control group consisted of 19 patients with coronary artery disease, angina FC I-III without anxiety disorders, whom treatment adaptol not been conducted. In each group, baseline, 1, 2 and 3 months were all methods of examination. The level of total cholesterol decreased significantly within a month after the treatment with 5,33±0,19 to 4,76±0,13 (p<0,05) in group I and 6,24±0.21 to 5,39±0,22 (p<0,05) in group II, the level of LDL cholesterol from 3,24±0,16 to 2,62±0,17 (p<0,05) in group I and from 3,65±0,20 to 3,02±0,19 (p<0,05) in group II. The level of triglycerides decreased after a month in patients of group II with 1,61±0,09 to 1,24±0,08 (p<0,05). This trend continued during the whole treatment adaptol and effect decreased, but not to the original values, a month after stopping treatment.

Conclusions: adaptol in patients with angina FC I-III reduces the level of total cholesterol, LDL cholesterol, triglycerides while taking it regardless of the presence or absence of anxiety disorders.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Ametov Alexander S.
Honored Scientist of the Russian Federation, Doctor of Medical Sciences, Professor, Head of Subdepartment of Endocrinology, Head of the UNESCO Network Chair on the subject «Bioethics of diabetes as a global problem» of the Russian Medical Academy of Continuous Professional Education (Moscow)
Вскрытие

Journals of «GEOTAR-Media»